Fundraising Fox

Montara Therapeutics

San Francisco, US · Founded 2022 · 2 known investors

montaratx.com ↗

Montara Therapeutics is a precision medicine neuroscience biotech developing brain-targeted therapies for neurological diseases via its BrainOnly platform and Brain-Targeting Chimeras (BrainTAC), which aim to concentrate drug activity in the brain and limit peripheral toxicity. Its work targets neurodegenerative and neurological conditions such as Parkinson's disease, tuberous sclerosis complex, and brain cancer.

BiotechDeep Techin /montara-therapeutics-inc

Founders & leadership

SS
Seth StrattonDirector
DL
Dirk LangdorfDirector
NH
Nicholas HertzExecutive Officer, Director

Investors · 2

Two Bear CapitalWhitefish · $3M – $10M
Dolby Family VenturesreportedSan Francisco

Reported raises · per SEC filings

Form D private placements
▶$20MraisedMar 2025 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Max LebovitzExecutive Officer
  • Seth StrattonDirector
  • Troy WilsonDirector
  • Zachary HillExecutive Officer
  • Rishi RakhitExecutive Officer
  • Randall ChinExecutive Officer
  • Dirk LangdorfDirector
  • Nicholas HertzExecutive Officer, Director, Promoter
Offering amount
$20M
Amount sold
$20M
First sale
Feb 2025
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8MraisedJan 2024 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Seth StrattonDirector
  • Dirk LangdorfDirector
  • Nicholas HertzExecutive Officer, Director
Offering amount
$17M
Amount sold
$8M
First sale
Jan 2024
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.